These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9616770)

  • 1. Functional anatomical and behavioral consequences of dopamine receptor stimulation.
    Wooten GF
    Ann N Y Acad Sci; 1997 Dec; 835():153-6. PubMed ID: 9616770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
    Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and behavioral output of the rat basal ganglia after intrastriatal infusion of d-amphetamine: lack of support for the basal ganglia model.
    Waszczak BL; Martin L; Boucher N; Zahr N; Sikes RW; Stellar JR
    Brain Res; 2001 Nov; 920(1-2):170-82. PubMed ID: 11716823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1/D2 actions of dopaminergic drugs studied with [14C]-2-deoxyglucose autoradiography.
    Trugman JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Sep; 19(5):795-810. PubMed ID: 8539420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anatomical connections of the basal ganglia].
    Fujiyama F
    Brain Nerve; 2009 Apr; 61(4):341-9. PubMed ID: 19378803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder.
    Wichmann T; DeLong MR
    Ann N Y Acad Sci; 2003 Jun; 991():199-213. PubMed ID: 12846988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperactive Response of Direct Pathway Striatal Projection Neurons to L-dopa and D1 Agonism in Freely Moving Parkinsonian Mice.
    Sagot B; Li L; Zhou FM
    Front Neural Circuits; 2018; 12():57. PubMed ID: 30104963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys.
    Hadipour-Niktarash A; Rommelfanger KS; Masilamoni GJ; Smith Y; Wichmann T
    J Neurophysiol; 2012 Mar; 107(5):1500-12. PubMed ID: 22131382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys.
    Kliem MA; Maidment NT; Ackerson LC; Chen S; Smith Y; Wichmann T
    J Neurophysiol; 2007 Sep; 98(3):1489-500. PubMed ID: 17634344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D; Karain B; Brantley E; Shi WX
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
    Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean-field modeling of the basal ganglia-thalamocortical system. I Firing rates in healthy and parkinsonian states.
    van Albada SJ; Robinson PA
    J Theor Biol; 2009 Apr; 257(4):642-63. PubMed ID: 19168074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
    Grace AA
    Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ultra-short dopamine pathway regulates basal ganglia output.
    Zhou FW; Jin Y; Matta SG; Xu M; Zhou FM
    J Neurosci; 2009 Aug; 29(33):10424-35. PubMed ID: 19692618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine.
    Walters JR; Hu D; Itoga CA; Parr-Brownlie LC; Bergstrom DA
    Neuroscience; 2007 Jan; 144(2):762-76. PubMed ID: 17112675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.